Verano Holdings (VRNO) Other Non-Current Liabilities (2022 - 2026)

Verano Holdings' (VRNO) quarterly Other Non-Current Liabilities came in at $1.5 million in Q1 2026, down 37.99% year-on-year from $2.5 million in Q1 2025, and up 42.37% on a QoQ basis from $1.1 million in Q4 2025.

Verano Holdings (VRNO) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 5 years of Other Non-Current Liabilities data on file, last reported at $1.5 million in Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities fell 37.99% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $1.5 million, a 37.99% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, down 43.43% from the prior year.
  • Other Non-Current Liabilities for Q1 2026 stood at $1.5 million, up from $1.1 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for VRNO reached as high as $66.9 million in Q2 2022 and fell as low as $255000.0 in Q4 2023.
  • Historically, Other Non-Current Liabilities has averaged $10.3 million across 5 years, with a median of $3.5 million in 2024.
  • Across the five-year window, Other Non-Current Liabilities sank 95.75% in 2023 and surged 649.41% in 2024, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $6.0 million in 2022, then sank by 95.75% to $255000.0 in 2023, then jumped by 649.41% to $1.9 million in 2024, then sank by 43.43% to $1.1 million in 2025, then soared by 42.37% to $1.5 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $1.5 million in Q1 2026, $1.1 million in Q4 2025, and $2.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Verano Holdings 2.02 Bn 1.94 Bn 98.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.54 Mn
Dec 31, 2025 1.08 Mn
Sep 30, 2025 2.16 Mn
Jun 30, 2025 1.42 Mn
Mar 31, 2025 2.48 Mn
Dec 31, 2024 1.91 Mn
Sep 30, 2024 5.01 Mn
Jun 30, 2024 3.78 Mn
Mar 31, 2024 3.24 Mn
Dec 31, 2023 255,000.00
Sep 30, 2023 4.95 Mn
Jun 30, 2023 4.95 Mn
Mar 31, 2023 5.74 Mn
Dec 31, 2022 5.99 Mn
Sep 30, 2022 53.74 Mn
Jun 30, 2022 66.90 Mn